TransMedics Group, Inc. · NASDAQ:TMDX

TransMedics Group, Inc. financial statements

TransMedics Group, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue605.5M441.5M241.6M93.5M30.3M25.6M23.6M13.0M7.68M6.21M
Cost of revenue242.7M179.5M87.5M28.2M9.10M9.00M9.74M7.28M5.55M5.44M
Gross profit362.8M262.1M154.1M65.3M21.2M16.6M13.9M5.73M2.14M766.0K
Research and development69.1M56.0M36.1M26.8M22.3M18.8M19.9M13.7M15.0M15.6M
Selling, general and administrative185.2M168.6M119.6M69.9M38.3M24.2M23.6M12.3M7.61M8.12M
Operating income108.6M37.5M-28.7M-31.4M-39.4M-26.4M-29.6M-20.2M-20.4M-23.0M
Depreciation and amortization27.2M19.8M8.18M3.48M1.82M1.58M1.22M769.0K630.0K426.0K
EBITDA135.8M57.3M-20.6M-28.0M-37.6M-24.8M-28.4M-19.5M-19.8M-22.6M
Interest expense13.8M14.4M10.8M3.73M3.87M3.98M4.35M2.72M1.07M979.0K
Income before tax107.5M35.8M-26.7M-36.2M-44.2M-28.7M-33.5M-23.7M-20.8M-24.1M
Income tax-82.8M316.0K-1.64M66.0K36.0K0000984.0K
Net income190.3M35.5M-25.0M-36.2M-44.2M-28.7M-33.5M-23.8M-20.8M-24.1M
Earnings per share, basic5.601.07-0.77-1.23-1.60-1.16-2.36-17.48-0.98-1.66
Earnings per share, diluted4.871.01-0.77-1.23-1.60-1.16-2.36-17.48

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents488.4M336.6M394.8M201.2M25.6M24.6M20.1M20.2M12.4M9.84M
Short-term investments066.9M101.1M60.6M012.7M38.0M
Receivables84.3M97.7M63.6M27.6M5.93M6.86M6.56M3.44M925.0K1.38M
Inventory48.9M46.6M44.2M20.6M14.9M11.9M11.2M9.28M7.97M6.33M
Current assets637.8M497.2M510.7M252.3M118.7M146.8M100.0M34.8M34.0M55.9M
Property, plant and equipment327.7M286.0M173.9M19.2M9.84M4.75M4.79M3.47M2.46M1.72M
Goodwill11.5M11.5M12.0M0
Total assets1.07B804.1M706.0M277.1M134.9M152.0M105.3M42.2M37.0M58.1M
Accounts payable10.3M10.3M12.7M3.34M6.65M1.21M7.25M4.72M3.52M4.25M
Current liabilities89.3M59.9M54.9M23.7M23.2M11.9M16.1M12.6M10.9M9.47M
Long-term debt502.4M509.3M506.2M58.7M35.2M34.7M34.1M33.7M6.85M8.41M
Total debt10.0M518.3M515.9M58.7M35.2M34.7M34.1M33.7M8.65M8.41M
Total liabilities595.3M575.5M568.8M89.8M67.0M48.1M50.6M47.9M205.7M19.3M
Shareholders' equity473.1M228.6M137.2M187.4M67.9M103.9M54.6M-192.2M-168.7M38.8M
Shares outstanding34.3M33.6M32.7M32.1M27.8M27.2M21.2M1.40M21.2M14.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations192.8M48.8M-13.0M-45.8M-28.9M-30.3M-32.3M-26.0M-23.1M-24.1M
Capital spending-59.3M-129.7M-151.8M-11.9M-3.52M-455.0K-165.0K-418.0K-263.0K-1.48M
Free cash flow133.6M-80.9M-164.9M-57.7M-32.4M-30.7M-32.5M-26.4M-23.4M-25.6M
Cash from investing-59.3M-129.3M-194.0M54.5M29.3M-41.6M-60.5M12.3M24.9M-39.7M
Cash from financing16.9M22.9M400.4M167.9M1.39M75.5M92.7M22.1M3.00K63.5M
Dividends paid-51.1M-357.0K
Share buybacks-138.0K955.0K509.0K419.0K357.0K202.0K46.0K3.00K63.6M
Change in cash151.7M-58.2M193.6M175.6M999.0K4.49M-149.0K8.30M2.10M-243.0K